Patents by Inventor Simon James Richards

Simon James Richards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230167086
    Abstract: The present invention provides a compound of Formula I: Formula I or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the compound and to methods of using the compound to treat physiological disorders.
    Type: Application
    Filed: April 23, 2021
    Publication date: June 1, 2023
    Inventor: Simon James RICHARDS
  • Patent number: 11066386
    Abstract: The present invention provides compounds of Formula II or a pharmaceutically acceptable salts thereof, useful as a CGRP receptor antagonist.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: July 20, 2021
    Assignee: Eli Lilly and Company
    Inventors: David Andrew Coates, Simon James Richards, Adam Jan Sanderson
  • Publication number: 20200181111
    Abstract: The present invention provides compounds of Formula II or a pharmaceutically acceptable salts thereof, useful as a CGRP receptor antagonist.
    Type: Application
    Filed: May 8, 2018
    Publication date: June 11, 2020
    Inventors: David Andrew Coates, Simon James Richards, Adam Jan Sanderson
  • Patent number: 10011610
    Abstract: The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: July 3, 2018
    Assignee: Eli Lilly and Company
    Inventors: David Michael Remick, Simon James Richards, Adam Jan Sanderson
  • Patent number: 9522923
    Abstract: The present invention provides a compound of Formula II: or a pharmaceutically acceptable salt thereof, that are inhibitors of BACE.
    Type: Grant
    Filed: February 17, 2016
    Date of Patent: December 20, 2016
    Assignee: Eli Lilly and Company
    Inventors: Simon James Richards, Erik James Hembre, Jose Eduardo Lopez, Leonard Larry Winneroski, Jr., Timothy Andrew Woods, Jennifer Anne McMahon
  • Publication number: 20160318953
    Abstract: The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 22, 2016
    Publication date: November 3, 2016
    Inventors: David Michael Remick, Simon James Richards, Adam Jan Sanderson
  • Publication number: 20160244465
    Abstract: The present invention provides a compound of Formula II: or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 17, 2016
    Publication date: August 25, 2016
    Inventors: Simon James Richards, Erik James Hembre, Jose Eduardo Lopez, Leonard Larry Winneroski, Jr., Timothy Andrew Woods, Jennifer Anne McMahon
  • Patent number: 8778946
    Abstract: The invention provides certain 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds, particularly compounds of formula I and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat Parkinsons disease Formula (I).
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: July 15, 2014
    Assignee: Eli Lilly and Company
    Inventors: Carlos Lamas-Peteira, Simon James Richards, Selma Sapmaz, Magnus Wilhelm Walter
  • Publication number: 20130225602
    Abstract: The invention provides certain 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds, particularly compounds of formula I and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat Parkinsons disease Formula (I).
    Type: Application
    Filed: November 17, 2011
    Publication date: August 29, 2013
    Applicant: ELI LILLY AND COMPANY
    Inventors: Carlos Lamas-Peteira, Simon James Richards, Selma Sapmaz, Magnus Wilhelm Walter
  • Publication number: 20080261999
    Abstract: Compounds of the formula I or a pharmaceutically acceptable salt thereof: processes for their preparation, pharmaceutical compositions which contain them and their uses in therapy.
    Type: Application
    Filed: February 23, 2006
    Publication date: October 23, 2008
    Inventors: Fionna Mitchell Martin, Claire June Flynn, Simon James Richards
  • Patent number: 6855715
    Abstract: Compounds of formula (I) where R2, each X, L, Y, Cy, Lp, D and n are as defined in the specification, are serine protease inhibitors useful as antithrombotic agents.
    Type: Grant
    Filed: June 13, 2000
    Date of Patent: February 15, 2005
    Assignee: Eli Lilly and Company
    Inventors: John Walter Liebeschuetz, Amanda Jane Lyons, Christopher William Murray, Andrew David Rimmer, Stephen Clinton Young, Nicholas Paul Camp, Stuart Donald Jones, Phillip John Morgan, Simon James Richards, William Alexander Wylie, John Joseph Masters, Michael Robert Wiley
  • Patent number: 6423199
    Abstract: An electrochemical ion exchange cell comprises a metal carbollide as ion exchange material. The carbollide is preferably a polynuclear cobalt dicarbollide and is typically substituted by chlorine. Also novel are polynuclear metal carbollides comprising a substituted carbollide cage, as well as metal carbollides comprising a carbollide cage substituted by a moiety having a —COOH or —SH group.
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: July 23, 2002
    Assignee: British Nuclear Fuels plc
    Inventors: Nigel Dennis Tinker, James Darcy McKinney, Simon James Richards